Brief: NGM Bio Reports Qtrly Loss Per Share Of $0.38
12/08/2020 21:39
Aug 12 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* NGM BIO PROVIDES BUSINESS HIGHLIGHTS AND REPORTS SECOND
QUARTER
2020 FINANCIAL RESULTS
* NGM BIOPHARMACEUTICALS INC - $312.1 MILLION IN CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2020
* NGM BIOPHARMACEUTICALS INC -
Source text for Eikon: ID:nGNX4ngMd5
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors